← Leaderboards
Jason Kwon
Indiana University Indianapolis
$364,601
Attributed
$364,601
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $147.2K · FY2017–23$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$364,601 · 3
By mechanism
F32$192,170 · 1
K99$147,150 · 1
F31$25,281 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- David W. Clapp$30,065,006
- Shannon Michelle Hawkins$2,933,997
- Charles B Goodwin$201,851
- Clark David Wells$1,534,605
- Lisa Deng Yuen$167,577
Others in their field
Other Emerging Leaders on “Proteins”
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
Research focus
ProteinsResistanceMalignant Neoplasm Of PancreasCancer CellReportingMalignant NeoplasmsInhibitor/AntagonistMeksMortalityLaboratoriesInsightGrowthKras2 GeneCancer Cell LineMass Spectrum AnalysisIn VivoBindingKnock-DownCellsEffective TherapyCrispr/Cas TechnologyBaseImmunoprecipitationEarly Diagnosis
Grant awards (5)
Structure and Function of the SHOC2 Holophosphatase Complex in RAS-driven Cancer$147,150
K99 · FY2023 · CA · contact PI
Elucidating the role of SHOC2 to enhance MEK inhibitor sensitivity in pancreatic cancer$66,390
F32 · FY2021 · CA · contact PI
Elucidating the role of SHOC2 to enhance MEK inhibitor sensitivity in pancreatic cancer$64,926
F32 · FY2020 · CA · contact PI
Elucidating the role of SHOC2 to enhance MEK inhibitor sensitivity in pancreatic cancer$60,854
F32 · FY2019 · CA · contact PI
Pathophysiological role and therapeutic potential of microRNA-29 in pancreatic cancer autophagy$25,281
F31 · FY2017 · CA · contact PI